-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - psoriatic arthritis: results of a six-
month, multicenter, randomized, double-
blind, placebo-controlled, phase … A phase II, multicenter, open-label study
evaluating dosing and preliminary safety
and efficacy of … AEs during double blind phase
included 159 events w/
tocilizumab vs 38 w/ placebo
including 60 infections
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - psoriatic arthritis: results of a six-
month, multicenter, randomized, double-
blind, placebo-controlled, phase … A phase II, multicenter, open-label study
evaluating dosing and preliminary safety
and efficacy of … AEs during double blind phase
included 159 events w/
tocilizumab vs 38 w/ placebo
including 60 infections
-
psnet.ahrq.gov/primer/coronavirus-disease-2019-covid-19-and-safety-older-adults
April 10, 2024 - reopen including: Criteria, based on an individual state’s level of community transmission, to determine phase … Reopening nursing homes–phase 1–how does it begin? CMS Compliance Group, Inc . May 21, 2020.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - not all effects are likely to become
evident in all patients within the one-to-two
month treatment phase … own “across study” subgroup analyses using
study-level data on our variables of interest
(e.g., phase … We are happy our interpretations were correct
for the controlled phase. … Thank you for sharing
the results from the open label phase, although
this does not meet our inclusion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
March 16, 2017 - not all effects are likely to become
evident in all patients within the one-to-two
month treatment phase … own “across study” subgroup analyses using
study-level data on our variables of interest
(e.g., phase … We are happy our interpretations were correct
for the controlled phase. … Thank you for sharing
the results from the open label phase, although
this does not meet our inclusion
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - Takeda
has completed a phase 1, randomized, open-label, 2 period,
crossover study to evaluate the effect … release
(MR) - The objective of the study was to assess the safety of
dexlansoprazole MR from the phase … Pediatric patients -
Dexlansoprazole is not FDA approved for use in patients less than 18
years of age.1A phase … dexlansoprazole in
adolescents 12-17 years of age with symptomatic GERD has been
completed.8 A second phase
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.jsp
July 01, 2016 - DOH feels that this project has set a good foundation for either taking this
activity into a pilot phase … Given the
current budget crisis, AHRQ may be able to kick start the next development phase by
providing
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.pdf
April 23, 2009 - DOH feels that this project has set a good foundation for either taking this
activity into a pilot phase … Given the
current budget crisis, AHRQ may be able to kick start the next development phase by
providing
-
www.ahrq.gov/sites/default/files/2024-01/schnipper-report.pdf
January 01, 2024 - was the long delay between sites signing up for the study (i.e., during the grant application
18
phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - psoriatic arthritis: results of a six-
month, multicenter, randomized, double-
blind, placebo-controlled, phase … A phase II, multicenter, open-label study
evaluating dosing and preliminary safety
and efficacy of … AEs during double blind phase
included 159 events w/
tocilizumab vs 38 w/ placebo
including 60 infections
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - psoriatic arthritis: results of a six-
month, multicenter, randomized, double-
blind, placebo-controlled, phase … A phase II, multicenter, open-label study
evaluating dosing and preliminary safety
and efficacy of … AEs during double blind phase
included 159 events w/
tocilizumab vs 38 w/ placebo
including 60 infections
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/z8AVsCHJEZUBSJtdSx424H
May 23, 2019 - episodic$ or alcoholic intoxication).mp.
4 1 or 2 or 3
5 limit 4 to (clinical trial or clinical trial, phase … i or clinical trial, phase ii or
clinical trial, phase iii or clinical trial, phase iv or controlled … episodic$ or alcoholic intoxication).mp.
4 1 or 2 or 3
5 limit 4 to (clinical trial or clinical trial, phase … i or clinical trial, phase ii or
clinical trial, phase iii or clinical trial, phase iv or controlled
-
ecareplan.ahrq.gov/collaborate/download/temp/downloadM2Uu4142558.zip?contentType=application/zip
May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned
Phase … with:
Single value term bindings
New or existing value sets
Cardinalities of attribute and elements
Phase … apps AND how to recruit and troubleshoot the apps for patients
44
User Acceptance Testing Approach
Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II
Phase II: Chaperoned patient and provider testing of both apps
Extend the model above with real patient
-
ecareplan.ahrq.gov/collaborate/download/temp/downloadJhlcp223213.zip?contentType=application/zip
May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned
Phase … with:
Single value term bindings
New or existing value sets
Cardinalities of attribute and elements
Phase … apps AND how to recruit and troubleshoot the apps for patients
44
User Acceptance Testing Approach
Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II
Phase II: Chaperoned patient and provider testing of both apps
Extend the model above with real patient
-
ecareplan.ahrq.gov/collaborate/download/temp/downloadAZ2BG222954.zip?contentType=application/zip
May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned
Phase … with:
Single value term bindings
New or existing value sets
Cardinalities of attribute and elements
Phase … apps AND how to recruit and troubleshoot the apps for patients
44
User Acceptance Testing Approach
Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II
Phase II: Chaperoned patient and provider testing of both apps
Extend the model above with real patient
-
ecareplan.ahrq.gov/collaborate/download/temp/downloadVatm6143310.zip?contentType=application/zip
May 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned
Phase … with:
Single value term bindings
New or existing value sets
Cardinalities of attribute and elements
Phase … apps AND how to recruit and troubleshoot the apps for patients
44
User Acceptance Testing Approach
Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II
Phase II: Chaperoned patient and provider testing of both apps
Extend the model above with real patient
-
cmext.ahrq.gov/confluence/download/export/downloadb6ZH1015505.zip?contentType=application/zip
September 01, 2022 - Review and modify NIDDK Chronic Kidney Disease (CKD) spreadsheet where data elements will be assigned
Phase … with:
Single value term bindings
New or existing value sets
Cardinalities of attribute and elements
Phase … apps AND how to recruit and troubleshoot the apps for patients
44
User Acceptance Testing Approach
Phase … Prepare for Chaperoned patient and provider testing by adjusting expectations and protocols to support Phase … II
Phase II: Chaperoned patient and provider testing of both apps
Extend the model above with real patient
-
digital.ahrq.gov/sites/default/files/docs/page/do_medicaid_schip_needsassessment2008_final.pdf
July 01, 2009 - health IT initiatives Number of agencies Agencies*
Two health IT initiatives, both in
implementation phase … 2 MO, NM
Two health IT initiatives, both in planning
phase
5 AZ, MN, NH, NV, OH
Two health IT … other being planned
9 DE, FL, GA, ME, MT, NC, OR, PA, TX
One health IT initiative in implementation
phase … 6 AL-Medicaid, CA, IA, MI, PR, WI
One health IT initiative in planning phase 6 AL-CHIP, CO, MD,
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpra.pdf
March 01, 2012 - Once the site visits had been completed, we created a series of tables for each surgical phase
(i.e. … The operative phase demonstrated the most
consistency across study sites with respect to the surgical … communications
tended to break down such as between the ASCs and physicians’ offices during the preoperative
phase … The use of simulation exercises can be beneficial in
this phase of the process.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpra.pdf
March 01, 2012 - Once the site visits had been completed, we created a series of tables for each surgical phase
(i.e. … The operative phase demonstrated the most
consistency across study sites with respect to the surgical … communications
tended to break down such as between the ASCs and physicians’ offices during the preoperative
phase … The use of simulation exercises can be beneficial in
this phase of the process.